High HER2 expression correlates with response to the combination of lapatinib and trastuzumab.
Auteurs : Scaltriti M, Nuciforo P, Bradbury I, Sperinde J, Agbor-Tarh D, Campbell C, Chenna A, Winslow J, Serra V, Parra JL, Prudkin L, Jimenez J, Aura C, Harbeck N, Pusztai L, Ellis C, Eidtmann H, Arribas J, Cortes J, de Azambuja E, Piccart-Gebhart M, Baselga J
Jaar : 2015
Journal : Clin Cancer Res
Volume : 21(3)
Pagina's : 569-76